{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:14:13Z","timestamp":1780560853874,"version":"3.54.1"},"reference-count":61,"publisher":"Pleiades Publishing Ltd","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1134\/s0006297925603466","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:06:44Z","timestamp":1773414404000},"page":"299-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MAPK\/ERK Signaling Pathway in Schizophrenia: Expression Levels of Regulatory Proteins in Peripheral Blood Mononuclear Cells"],"prefix":"10.1134","volume":"91","author":[{"given":"Anastasiia S.","family":"Boiko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan S.","family":"Kopnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Epimakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena G.","family":"Kornetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"3006_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/genes12121850","volume":"12","author":"M. H. Wahbeh","year":"2021","unstructured":"Wahbeh, M. H., and Avramopoulos, D. (2021) Gene-environment interactions in schizophrenia: a literature review, Genes (Basel), 12, 1850, \nhttps:\/\/doi.org\/10.3390\/genes12121850.","journal-title":"Genes (Basel)"},{"key":"3006_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mcna.2022.05.005","volume":"107","author":"J. Faden","year":"2023","unstructured":"Faden, J., and Citrome, L. (2023) Schizophrenia: one name, many different manifestations, Med. Clin. North Am., 107, 61-72, \nhttps:\/\/doi.org\/10.1016\/j.mcna.2022.05.005.","journal-title":"Med. Clin. North Am."},{"key":"3006_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.30629\/2618-6667-2024-22-4-34-42","volume":"22","author":"A. B. Shmukler","year":"2024","unstructured":"Shmukler, A. B. (2024) Clinical picture and social behavior of patients with schizophrenia [in Russian], Psychiatry, 22, 34-42, \nhttps:\/\/doi.org\/10.30629\/2618-6667-2024-22-4-34-42.","journal-title":"Psychiatry"},{"key":"3006_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.26617\/1810-3111-2025-2(127)-15-32","volume":"2","author":"E. G. Kornetova","year":"2025","unstructured":"Kornetova, E. G., Galkin, S. A., Kornetov, A. N., Ivanova, S. A., and Bokhan, N. A. (2025) Phenotypes of schizophrenia [in Russian], Sib. Herald Psychiatry Narcol., 2, 15-32, \nhttps:\/\/doi.org\/10.26617\/1810-3111-2025-2(127)-15-32.","journal-title":"Sib. Herald Psychiatry Narcol."},{"key":"3006_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.20538\/1682-0363-2019-2-107-118","volume":"18","author":"A. N. Kornetov","year":"2019","unstructured":"Kornetov, A. N., Kornetova, E. G., Golenkova, A. V., Kozlova, S. M., Arzhanik, M. B., Samoilenko, Zh. A., Boiko, A. S., and Semke, A.\u00a0V. (2019) Neurocognitive deficit in the clinical polymorphism of schizophrenia: typology, severity, and syndromal overlaps [in Russian], Bull. Sib. Med., 18, 107-118, \nhttps:\/\/doi.org\/10.20538\/1682-0363-2019-2-107-118.","journal-title":"Bull. Sib. Med."},{"key":"3006_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.36107\/hfb.2019.i1.s163","volume":"1","author":"A. M. Reznik","year":"2019","unstructured":"Reznik, A. M., Kostyuk, G. P., Morozova, A. Yu., and Zakharova, N. V. (2019) Problems of schizophrenia precursors based on molecular genetic studies [in Russian], Health Food Biotechnol., 1, 27-45, \nhttps:\/\/doi.org\/10.36107\/hfb.2019.i1.s163.","journal-title":"Health Food Biotechnol."},{"key":"3006_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.876749","volume":"13","author":"R. Jun","year":"2022","unstructured":"Jun, R., Zhang, W., Beacher, N. J., Zhang, Y., Li, Y., and Lin, D. T. (2022) Dysbindin-1, BDNF, and GABAergic transmission in schizophrenia, Front. Psychiatry, 13, 876749, \nhttps:\/\/doi.org\/10.3389\/fpsyt.2022.876749.","journal-title":"Front. Psychiatry"},{"key":"3006_CR8","first-page":"42","volume":"2","author":"V. V. Vanyukov","year":"2024","unstructured":"Vanyukov, V. V., Gulyaeva, I. L., Ganeeva, E. R., Sukhanova, O. S., Zhvakina, E. A., Minkhazeva, E. M., and Balueva, T. A. (2024) Modern understanding of the etiology and pathogenesis of schizophrenia [In Russian], Perm Med.\u00a0J., 2, 42-51.","journal-title":"Perm Med.\u00a0J."},{"key":"3006_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05001-5","author":"A. K. Gupta","year":"2025","unstructured":"Gupta, A. K., Gupta, S., Mehan, S., Khan, Z., Das Gupta, G., and Narula, A. S. (2025) Exploring the connection between BDNF\/TrkB and AC\/cAMP\/PKA\/CREB signaling pathways: potential for neuroprotection and therapeutic targets for neurological disorders, Mol. Neurobiol., \nhttps:\/\/doi.org\/10.1007\/s12035-025-05001-5.","journal-title":"Mol. Neurobiol."},{"key":"3006_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3934\/Neuroscience.2023002","volume":"10","author":"R. Ahmad","year":"2023","unstructured":"Ahmad, R., Azman, K. F., Yahaya, R., Shafin, N., Omar, N., Ahmad, A. H., Zakaria, R., Wijaya, A., and Othman, Z. (2023) Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions, AIMS Neurosci., 10, 5-32, \nhttps:\/\/doi.org\/10.3934\/Neuroscience.2023002.","journal-title":"AIMS Neurosci."},{"key":"3006_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/7854_2010_41","volume":"4","author":"M. Kvajo","year":"2010","unstructured":"Kvajo, M., McKellar, H., and Gogos, J. A. (2010) Molecules, signaling, and schizophrenia, Curr. Top. Behav. Neurosci., 4, 629-656, \nhttps:\/\/doi.org\/10.1007\/7854_2010_41.","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"3006_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jpsychires.2014.06.008","volume":"57","author":"L. Ma","year":"2014","unstructured":"Ma, L., Wu, D. D., Ma, S. L., Tan, L., Chen, X., Tang, N. L., and Yao, Y. G. (2014) Molecular evolution in the CREB1 signal pathway and a rare haplotype in CREB1 with genetic predisposition to schizophrenia, J.\u00a0Psychiatr. Res., 57, 84-89, \nhttps:\/\/doi.org\/10.1016\/j.jpsychires.2014.06.008.","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"3006_CR13","first-page":"212","volume":"4","author":"A. S. Boiko","year":"2016","unstructured":"Boiko, A. S., Losenkov, I. S., and Dmitrieva, E. G. (2016) Application of multiplex analysis for determining peripheral biomarkers in schizophrenia patients receiving long-term antipsychotic therapy [in Russian], Dev. Registr. Med., 4, 212-217.","journal-title":"Dev. Registr. Med."},{"key":"3006_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13020163","volume":"13","author":"A. Gliwi\u0144ska","year":"2023","unstructured":"Gliwi\u0144ska, A., Czubili\u0144ska-\u0141ada, J., Wi\u0119ckiewicz, G., \u015awi\u0119tochowska, E., Bade\u0144ski, A., Dworak, M., and Szczepa\u0144ska, M. (2023) The role of brain-derived neurotrophic factor (BDNF) in diagnosis and treatment of epilepsy, depression, schizophrenia, anorexia nervosa and Alzheimer\u2019s disease as highly drug-resistant diseases: a narrative review, Brain Sci., 13, 163, \nhttps:\/\/doi.org\/10.3390\/brainsci13020163.","journal-title":"Brain Sci."},{"key":"3006_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011204","volume":"25","author":"A. Liberona","year":"2024","unstructured":"Liberona, A., Jones, N., Z\u00fa\u00f1iga, K., Garrido, V., Zelada, M. I., Silva, H., and Nieto, R. R. (2024) Brain-derived neurotrophic factor (BDNF) as a predictor of treatment response in schizophrenia and bipolar disorder: a systematic review, Int.\u00a0J. Mol. Sci., 25, 11204, \nhttps:\/\/doi.org\/10.3390\/ijms252011204.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"3006_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature11860","volume":"493","author":"D. H. Ebert","year":"2013","unstructured":"Ebert, D. H., and Greenberg, M. E. (2013) Activity-dependent neuronal signalling and autism spectrum disorder, Nature, 493, 327-337, \nhttps:\/\/doi.org\/10.1038\/nature11860.","journal-title":"Nature"},{"key":"3006_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/0-387-30128-3_7","volume":"557","author":"G. M. Ratto","year":"2006","unstructured":"Ratto, G. M., and Pizzorusso, T. (2006) A\u00a0kinase with a vision: role of ERK in the synaptic plasticity of the visual cortex, Adv. Exp. Med. Biol., 557, 122-132, \nhttps:\/\/doi.org\/10.1007\/0-387-30128-3_7.","journal-title":"Adv. Exp. Med. Biol."},{"key":"3006_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122282","volume":"336","author":"Y. Wang","year":"2024","unstructured":"Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., and Cheng, L. (2024) TrkB\/BDNF signaling pathway and its small molecular agonists in CNS injury, Life Sci., 336, 122282, \nhttps:\/\/doi.org\/10.1016\/j.lfs.2023.122282.","journal-title":"Life Sci."},{"key":"3006_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207777","volume":"21","author":"L. Colucci-D'Amato","year":"2020","unstructured":"Colucci-D'Amato, L., Speranza, L., and Volpicelli, F. (2020) Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer, Int.\u00a0J. Mol. Sci., 21, 7777, \nhttps:\/\/doi.org\/10.3390\/ijms21207777.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"3006_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","volume":"185","author":"C. S. Wang","year":"2022","unstructured":"Wang, C. S., Kavalali, E. T., and Monteggia, L. M. (2022) BDNF signaling in context: From synaptic regulation to psychiatric disorders, Cell, 185, 62-76, \nhttps:\/\/doi.org\/10.1016\/j.cell.2021.12.003.","journal-title":"Cell"},{"key":"3006_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0006-3223(99)00104-3","volume":"46","author":"S. V. Kyosseva","year":"1999","unstructured":"Kyosseva, S. V., Elbein, A. D., Sue, W., Griffin, T., Mrak, R. E., Lyon, M., and Karson, C. N. (1999) Mitogen-activated protein kinases in schizophrenia, Biol. Psychiatry, 46, 689-696, \nhttps:\/\/doi.org\/10.1016\/S0006-3223(99)00104-3.","journal-title":"Biol. Psychiatry"},{"key":"3006_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112876","volume":"396","author":"A. R. Deane","year":"2021","unstructured":"Deane, A. R., Potemkin, N., and Ward, R. D. (2021) Mitogen-activated protein kinase (MAPK) signalling corresponds with distinct behavioural profiles in a rat model of maternal immune activation, Behav. Brain Res., 396, 112876, \nhttps:\/\/doi.org\/10.1016\/j.bbr.2020.112876.","journal-title":"Behav. Brain Res."},{"key":"3006_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.neubiorev.2021.10.009","volume":"131","author":"J. D. Iroegbu","year":"2021","unstructured":"Iroegbu, J. D., Ijomone, O. K., Femi-Akinlosotu, O. M., and Ijomone, O. M. (2021) ERK\/MAPK signalling in the developing brain: perturbations and consequences, Neurosci. Biobehav. Rev., 131, 792-805, \nhttps:\/\/doi.org\/10.1016\/j.neubiorev.2021.10.009.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"3006_CR24","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19708","volume":"13","author":"J. Xie","year":"2025","unstructured":"Xie, J., Sun, S., Li, Q., Chen, Y., Huang, L., Wang, D., and Wang, Y. (2025) MAPK\/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential, PeerJ, 13, e19708, \nhttps:\/\/doi.org\/10.7717\/peerj.19708.","journal-title":"PeerJ"},{"key":"3006_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","volume":"68","author":"P. P. Roux","year":"2004","unstructured":"Roux, P. P., and Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions, Microbiol. Mol. Biol. Rev., 68, 320-344, \nhttps:\/\/doi.org\/10.1128\/MMBR.68.2.320-344.2004.","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"3006_CR26","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"Y. J. Guo","year":"2020","unstructured":"Guo, Y. J., Pan, W. W., Liu, S. B., Shen, Z. F., Xu, Y., and Hu, L. L. (2020) ERK\/MAPK signalling pathway and tumorigenesis, Exp. Ther. Med., 19, 1997-2007, \nhttps:\/\/doi.org\/10.3892\/etm.2020.8454.","journal-title":"Exp. Ther. Med."},{"key":"3006_CR27","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-021-00732-8","volume":"23","author":"G. Zhu","year":"2021","unstructured":"Zhu, G., Herlyn, M., and Yang, X. (2021) TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination, Nat. Cell Biol., 23, 978-991, \nhttps:\/\/doi.org\/10.1038\/s41556-021-00732-8.","journal-title":"Nat. Cell Biol."},{"key":"3006_CR28","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1523\/JNEUROSCI.19-11-04337.1999","volume":"19","author":"E. D. Roberson","year":"1999","unstructured":"Roberson, E. D., English, J. D., Adams, J. P., Selcher, J. C., Kondratick, C., and Sweatt, J. D. (1999) The\u00a0mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus, J.\u00a0Neurosci., 19, 4337-4348, \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.19-11-04337.1999.","journal-title":"J.\u00a0Neurosci."},{"key":"3006_CR29","doi-asserted-by":"publisher","first-page":"27527","DOI":"10.1074\/jbc.M701077200","volume":"282","author":"J. N. Gelinas","year":"2007","unstructured":"Gelinas, J. N., Banko, J. L., Hou, L., Sonenberg, N., Weeber, E. J., Klann, E., and Nguyen, P. V. (2007) ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation machinery to gate induction of protein synthesis-dependent long-term potentiation, J.\u00a0Biol. Chem., 282, 27527-27535, \nhttps:\/\/doi.org\/10.1074\/jbc.M701077200.","journal-title":"J.\u00a0Biol. Chem."},{"key":"3006_CR30","doi-asserted-by":"publisher","first-page":"15951","DOI":"10.1073\/pnas.0913875107","volume":"107","author":"M. A. Patterson","year":"2010","unstructured":"Patterson, M. A., Szatmari, E. M., and Yasuda, R. (2010) AMPA receptors are exocytosed in stimulated spines and adjacent dendrites in a Ras-ERK-dependent manner during long-term potentiation, Proc. Natl. Acad. Sci. USA, 107, 15951-15956, \nhttps:\/\/doi.org\/10.1073\/pnas.0913875107.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3006_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118020","volume":"257","author":"M. Amidfar","year":"2020","unstructured":"Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., and Kim, Y. K. (2020) The\u00a0role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease, Life Sci., 257, 118020, \nhttps:\/\/doi.org\/10.1016\/j.lfs.2020.118020.","journal-title":"Life Sci."},{"key":"3006_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jad.2020.09.076","volume":"278","author":"J. Yang","year":"2021","unstructured":"Yang, J., Li, S., Lv, H., Wang, W., Zhang, J., Chu, L., and Zhang, Y. (2021) CREB1 and BDNF gene polymorphisms are associated with early treatment response to escitalopram in panic disorder, J.\u00a0Affect. Disord., 278, 536-541, \nhttps:\/\/doi.org\/10.1016\/j.jad.2020.09.076.","journal-title":"J.\u00a0Affect. Disord."},{"key":"3006_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106099","volume":"177","author":"S. N. Zarneshan","year":"2022","unstructured":"Zarneshan, S. N., Fakhri, S., and Khan, H. (2022) Targeting Akt\/CREB\/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: a mechanistic approach, Pharmacol. Res., 177, 106099, \nhttps:\/\/doi.org\/10.1016\/j.phrs.2022.106099.","journal-title":"Pharmacol. Res."},{"key":"3006_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0378-1119(02)00398-0","volume":"285","author":"T. Kisseleva","year":"2002","unstructured":"Kisseleva, T., Bhattacharya, S., Braunstein, J., and Schindler, C. W. (2002) Signaling through the JAK\/STAT pathway, recent advances and future challenges, Gene, 285, 1-24, \nhttps:\/\/doi.org\/10.1016\/s0378-1119(02)00398-0.","journal-title":"Gene"},{"key":"3006_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083395","volume":"8","author":"D. J. Gough","year":"2013","unstructured":"Gough, D. J., Koetz, L., and Levy, D. E. (2013) The\u00a0MEK\u2013ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and Ras-mediated transformation, PLoS One, 8, e83395, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0083395.","journal-title":"PLoS One"},{"key":"3006_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17111781","volume":"17","author":"A. E. Temple","year":"2025","unstructured":"Temple, A. E., and Walker, S. R. (2025) The\u00a0roles of STAT3 and STAT5 in breast cancer, Cancers (Basel), 17, 1781, \nhttps:\/\/doi.org\/10.3390\/cancers17111781.","journal-title":"Cancers (Basel)"},{"key":"3006_CR37","doi-asserted-by":"publisher","first-page":"15150","DOI":"10.1080\/07391102.2023.2187232","volume":"41","author":"A. Bhattacharjee","year":"2023","unstructured":"Bhattacharjee, A., Pranto, S. M. A. M., Ahammad, I., Chowdhury, Z. M., Juliana, F. M., Das, K. C., Keya, C. A., and Salimullah, M. (2023) High risk genetic variants of human insulin receptor substrate\u00a01(IRS1) infer structural instability and functional interference, J.\u00a0Biomol. Struct. Dyn., 41, 15150-15164, \nhttps:\/\/doi.org\/10.1080\/07391102.2023.2187232.","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"3006_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1543319","volume":"12","author":"G. Gao","year":"2025","unstructured":"Gao, G., Chen, A., Yan, Y., Sagor, M. I. H., Lin, W., Lin, H., Lian, G., Xie, L., and Luo, L. (2025) Role of insulin signaling dysregulation in pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension, Front. Cardiovasc. Med., 12, 1543319, \nhttps:\/\/doi.org\/10.3389\/fcvm.2025.1543319.","journal-title":"Front. Cardiovasc. Med."},{"key":"3006_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0171-2985(97)80025-3","volume":"198","author":"K. Schulze-Osthoff","year":"1997","unstructured":"Schulze-Osthoff, K., Ferrari, D., Riehemann, K., and Wesselborg, S. (1997) Regulation of NF-kappa\u00a0B activation by MAP kinase cascades, Immunobiology, 198, 35-49, \nhttps:\/\/doi.org\/10.1016\/s0171-2985(97)80025-3.","journal-title":"Immunobiology"},{"key":"3006_CR40","first-page":"39","volume":"1","author":"E. S. Gershtein","year":"2013","unstructured":"Gershtein, E. S., Shcherbakov, A. M., and Kushlinsky, N. E. (2013) Clinical studies of NF-\u03baB signaling pathway components in breast malignancies [in Russian], Lab. Service, 1, 39-45.","journal-title":"Lab. Service"},{"key":"3006_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01607-0","volume":"11","author":"C. E. Murphy","year":"2021","unstructured":"Murphy, C. E., Walker, A. K., and Weickert, C. S. (2021) Neuroinflammation in schizophrenia: the role of nuclear factor kappa\u00a0B, Transl. Psychiatry, 11, 528, \nhttps:\/\/doi.org\/10.1038\/s41398-021-01607-0.","journal-title":"Transl. Psychiatry"},{"key":"3006_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L. Ma","year":"2005","unstructured":"Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., and Pandolfi, P. P. (2005) Phosphorylation and functional inactivation of TSC2 by Erk, Cell, 121, 179-193, \nhttps:\/\/doi.org\/10.1016\/j.cell.2005.02.031.","journal-title":"Cell"},{"key":"3006_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1188371","volume":"13","author":"Q. Y. Zhu","year":"2023","unstructured":"Zhu, Q. Y., He, Z. M., Cao, W. M., and Li, B. (2023) The\u00a0role of TSC2 in breast cancer: a literature review, Front. Oncol., 13, 1188371, \nhttps:\/\/doi.org\/10.3389\/fonc.2023.1188371.","journal-title":"Front. Oncol."},{"key":"3006_CR44","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/s0092-8674(04)00115-1","volume":"116","author":"R. J. Kelleher","year":"2004","unstructured":"Kelleher, R. J., Govindarajan, A., Jung, H. Y., Kang, H., and Tonegawa, S. (2004) Translational control by MAPK signaling in long-term synaptic plasticity and memory, Cell, 116, 467-479, \nhttps:\/\/doi.org\/10.1016\/s0092-8674(04)00115-1.","journal-title":"Cell"},{"key":"3006_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuropharm.2014.01.039","volume":"80","author":"A. Ciccarelli","year":"2014","unstructured":"Ciccarelli, A., and Giustetto, M. (2014) Role of ERK signaling in activity-dependent modifications of histone proteins, Neuropharmacology, 80, 34-44, \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.039.","journal-title":"Neuropharmacology"},{"key":"3006_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/bs.pbr.2018.09.008","volume":"241","author":"J. Vithayathil","year":"2018","unstructured":"Vithayathil, J., Pucilowska, J., and Landreth, G. E. (2018) ERK\/MAPK signaling and autism spectrum disorders, Prog. Brain Res., 241, 63-112, \nhttps:\/\/doi.org\/10.1016\/bs.pbr.2018.09.008.","journal-title":"Prog. Brain Res."},{"key":"3006_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"S. R. Kay","year":"1987","unstructured":"Kay, S. R., Opler, L. A., and Fiszbein, A. (1987) The\u00a0Positive and Negative Syndrome Scale (PANSS) for schizophrenia, Schizophr. Bull., 13, 261-276, \nhttps:\/\/doi.org\/10.1093\/schbul\/13.2.261.","journal-title":"Schizophr. Bull."},{"key":"3006_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1006\/abbi.1999.1341","volume":"369","author":"J. A. Grigorieva","year":"1999","unstructured":"Grigorieva, J. A., Dainiak, M. B., Katrukha, A. G., and Muronetz, V. I. (1999) Antibodies to the nonnative forms of d-glyceraldehyde-3-phosphate dehydrogenase: identification, purification, and influence on the renaturation of the enzyme, Arch. Biochem. Biophys., 369, 252-260, \nhttps:\/\/doi.org\/10.1006\/abbi.1999.1341.","journal-title":"Arch. Biochem. Biophys."},{"key":"3006_CR49","unstructured":"Tiganov, A. S., Snezhnevsky, A. V., and Orlovskaya, D. D. (1999) Guide to psychiatry [in Russian], (A. S. Tiganov, ed) Vol.\u00a01, Meditsina."},{"key":"3006_CR50","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.jpsychires.2013.08.019","volume":"47","author":"I. G. Barbosa","year":"2013","unstructured":"Barbosa, I. G., Nogueira, C. R., Rocha, N. P., Queiroz, A. L., Vago, J. P., Tavares, L. P., Assis, F., Fagundes, C. T., Huguet, R. B., Bauer, M. E., Teixeira, A. L., and de Sousa, L. P. (2013) Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD\u00a0patients, J.\u00a0Psychiatr. Res., 47, 1949-1954, \nhttps:\/\/doi.org\/10.1016\/j.jpsychires.2013.08.019.","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"3006_CR51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/pcn.12938","volume":"74","author":"M. Subbanna","year":"2020","unstructured":"Subbanna, M., Shivakumar, V., Venugopal, D., Narayanaswamy, J. C., Berk, M., Varambally, S., Venkatasubramanian, G., and Debnath, M. (2020) Impact of antipsychotic medication on IL-6\/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients, Psychiatry Clin. Neurosci., 74, 64-69, \nhttps:\/\/doi.org\/10.1111\/pcn.12938.","journal-title":"Psychiatry Clin. Neurosci."},{"key":"3006_CR52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1248\/bpb.b22-00887","volume":"46","author":"T. Matsuda","year":"2023","unstructured":"Matsuda, T. (2023) The\u00a0physiological and pathophysiological role of IL-6\/STAT3-mediated signal transduction and STAT3 binding partners in therapeutic applications, Biol. Pharm. Bull., 46, 364-378, \nhttps:\/\/doi.org\/10.1248\/bpb.b22-00887.","journal-title":"Biol. Pharm. Bull."},{"key":"3006_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01749-w","volume":"18","author":"G. Morris","year":"2020","unstructured":"Morris, G., Puri, B. K., Olive, L., Carvalho, A., Berk, M., Walder, K., Gustad, L. T., and Maes, M. (2020) Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments, BMC Med., 18, 305, \nhttps:\/\/doi.org\/10.1186\/s12916-020-01749-w.","journal-title":"BMC Med."},{"key":"3006_CR54","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/npp.2012.215","volume":"38","author":"P. Roussos","year":"2013","unstructured":"Roussos, P., Katsel, P., Davis, K. L., Giakoumaki, S. G., Lencz, T., Malhotra, A. K., Siever, L. J., Bitsios, P., and Haroutunian, V. (2013) Convergent findings for abnormalities of the NF-\u03baB signaling pathway in schizophrenia, Neuropsychopharmacology, 38, 533-539, \nhttps:\/\/doi.org\/10.1038\/npp.2012.215.","journal-title":"Neuropsychopharmacology"},{"key":"3006_CR55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","volume":"28","author":"A. Gladkevich","year":"2004","unstructured":"Gladkevich, A., Kauffman, H. F., and Korf, J. (2004) Lymphocytes as a neural probe: potential for studying psychiatric disorders, Prog. Neuropsychopharmacol. Biol. Psychiatry, 28, 559-576, \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2004.01.009.","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3006_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"E. S. Emamian","year":"2004","unstructured":"Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., and Gogos, J. A. (2004) Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia, Nat. Genet., 36, 131-137, \nhttps:\/\/doi.org\/10.1038\/ng1296.","journal-title":"Nat. Genet."},{"key":"3006_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40291-021-00516-8","volume":"25","author":"J. Goossens","year":"2021","unstructured":"Goossens, J., Morrens, M., and Coppens, V. (2021) The\u00a0potential use of peripheral blood mononuclear cells as biomarkers for treatment response and outcome prediction in psychiatry: a systematic review, Mol. Diagn. Ther., 25, 283-299, \nhttps:\/\/doi.org\/10.1007\/s40291-021-00516-8.","journal-title":"Mol. Diagn. Ther."},{"key":"3006_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5114\/ppn.2022.117963","volume":"31","author":"P. Rok-Bujko","year":"2022","unstructured":"Rok-Bujko, P. (2022) Molecular mechanisms of antipsychotics\u00a0\u2013 their influence on intracellular signaling pathways, and epigenetic and post-transcription processes, Postep. Psychiatr. Neurol., 31, 74-84, \nhttps:\/\/doi.org\/10.5114\/ppn.2022.117963.","journal-title":"Postep. Psychiatr. Neurol."},{"key":"3006_CR59","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.euroneuro.2008.12.007","volume":"19","author":"S. W. Park","year":"2009","unstructured":"Park, S. W., Lee, J. G., Ha, E. K., Choi, S. M., Cho, H. Y., Seo, M. K., and Kim, Y. H. (2009) Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells, Eur. Neuropsychopharmacol., 19, 356-362, \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2008.12.007.","journal-title":"Eur. Neuropsychopharmacol."},{"key":"3006_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pharmthera.2009.06.001","volume":"124","author":"R. Molteni","year":"2009","unstructured":"Molteni, R., Calabrese, F., Racagni, G., Fumagalli, F., and Riva, M. A. (2009) Antipsychotic drug actions on gene modulation and signaling mechanisms, Pharmacol. Ther., 124, 74-85, \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2009.06.001.","journal-title":"Pharmacol. Ther."},{"key":"3006_CR61","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.pharep.2018.05.005","volume":"70","author":"M. J\u00f3\u017awiak-B\u0119benista","year":"2018","unstructured":"J\u00f3\u017awiak-B\u0119benista, M., Jasi\u0144ska-Stroschein, M., and Kowalczyk, E. (2018) Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs, Pharmacol. Rep., 70, 1032-1039, \nhttps:\/\/doi.org\/10.1016\/j.pharep.2018.05.005.","journal-title":"Pharmacol. Rep."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297925603466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297925603466","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297925603466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:19:26Z","timestamp":1773620366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297925603466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3006"],"URL":"https:\/\/doi.org\/10.1134\/s0006297925603466","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      The study was approved by the Bioethics Committee of the Mental Health Research Institute, Tomsk National Medical Research Center (protocol no.\u00a0165; September\u00a018, 2023) and conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. All participants were informed about the study objectives and potential complications and provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}